1,258
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden

, , &
Pages 168-178 | Published online: 08 Feb 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Simone Rivolo, Jane Loftus, Balazs Peter, Marion Fahey & Thitima Kongnakorn. (2023) Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland. Journal of Medical Economics 26:1, pages 963-972.
Read now
Fritz Haverkamp & Christoph Gasteyger. (2011) A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children. Journal of Medical Economics 14:4, pages 448-457.
Read now

Articles from other publishers (8)

Molly C. Murton, Emma L. A. Drane, Danielle M. Goff-Leggett, Renée Shediac, Jamie O’Hara, Melita Irving & Thomas J. Butt. (2023) Burden and Treatment of Achondroplasia: A Systematic Literature Review. Advances in Therapy 40:9, pages 3639-3680.
Crossref
Ji Hyun Kim, Jun Ah Lee, Dong Ho Kim & Jung Sub Lim. (2019) Korean reference for full-term birth length by sex: data from the 4th Korean National Health and Nutrition Examination Survey (KNHANES-IV; 2007–2009). Annals of Pediatric Endocrinology & Metabolism 24:4, pages 226-230.
Crossref
Jennifer Gilbert. (2018) Initiating growth hormone therapy in children. Nurse Prescribing 16:6, pages 268-273.
Crossref
Mariel Pizarro, Herman Soto, Mauricio Rodríguez, Rosa María Galindo, Emilio Muciño & Patricia Medina Bravo. (2014) Evaluación económica del uso de rhGH solución inyectable de 36 UI en niños con deficiencia de hormona de crecimiento, síndrome de Turner y síndrome de Prader-Willi en México. PharmacoEconomics Spanish Research Articles 12:2, pages 47-52.
Crossref
Pinchas Cohen, Wayne Weng, Alan D. Rogol, Ron G. Rosenfeld, Anne‐Marie Kappelgaard & John Germak. (2014) Dose‐sparing and safety‐enhancing effects of an IGF ‐I‐based dosing regimen in short children treated with growth hormone in a 2‐year randomized controlled trial: therapeutic and pharmacoeconomic considerations . Clinical Endocrinology 81:1, pages 71-76.
Crossref
Jung Sub LimSe Won LimJu Hyun AhnBong Sub SongKye Shik ShimIl Tae Hwang. (2014) New Korean reference for birth weight by gestational age and sex: data from the Korean Statistical Information Service (2008-2012). Annals of Pediatric Endocrinology & Metabolism 19:3, pages 146.
Crossref
Steven D. Chernausek. (2012) Update: Consequences of Abnormal Fetal Growth. The Journal of Clinical Endocrinology & Metabolism 97:3, pages 689-695.
Crossref
Tomasz Romer, Markus Zabransky, Mieczyslaw Walczak, Mieczyslaw Szalecki & Sigrid Balser. (2011) Effect of switching recombinant human growth hormone: Comparative analysis of phase 3 clinical data. Biologics in Therapy 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.